Blue Fin Capital’s CVS Health CVS Stock Holding History

Blue Fin Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,684	Closed	-$513K	–	143
2024 Q2	$513K	Sell	8,684 -2,769	-24%	-$173K	0.1%	93
2024 Q1	$913K	Sell	11,453 -9,388	-45%	-$717K	0.2%	75
2023 Q4	$1.65M	Sell	20,841 -5,491	-21%	-$391K	0.42%	51
2023 Q3	$1.84M	Sell	26,332 -2,668	-9%	-$189K	0.54%	42
2023 Q2	$2M	Sell	29,000 -3	-0%	-$213	0.57%	39
2023 Q1	$2M	Buy	29,003 +1,448	+5%	+$121K	0.64%	37
2022 Q4	$2.57M	Sell	27,555 -259	-0.9%	-$25K	0.94%	31
2022 Q3	$2.65M	Sell	27,814 -975	-3%	-$96.5K	1%	28
2022 Q2	$2.67M	Sell	28,789 -171	-0.6%	-$16.7K	0.94%	29
2022 Q1	$2.93M	Sell	28,960 -159	-0.5%	-$16.7K	0.85%	31
2021 Q4	$3M	Sell	29,119 -95	-0.3%	-$8.78K	0.83%	30
2021 Q3	$2.48M	Sell	29,214 -1,058	-3%	-$88.6K	0.76%	34
2021 Q2	$2.52M	Sell	30,272 -1,367	-4%	-$112K	0.78%	34
2021 Q1	$2.38M	Buy	31,639 +1,393	+5%	+$101K	0.82%	32
2020 Q4	$2.06M	Buy	30,246 +5,507	+22%	+$358K	0.74%	36
2020 Q3	$1.44M	Buy	24,739 +793	+3%	+$49.3K	0.58%	46
2020 Q2	$1.55M	Buy	23,946 +1,075	+5%	+$67.7K	0.69%	39
2020 Q1	$1.36M	Buy	22,871 +1,254	+6%	+$83.7K	0.75%	41
2019 Q4	$1.6M	Buy	21,617 +426	+2%	+$29.9K	0.75%	37
2019 Q3	$1.34M	Buy	21,191 +1,057	+5%	+$62.6K	0.7%	46
2019 Q2	$1.1M	Buy	20,134 +114	+0.6%	+$6.14K	0.57%	57
2019 Q1	$1.08M	Sell	20,020 -302	-1%	-$18.6K	0.57%	54
2018 Q4	$1.33M	Sell	20,322 -886	-4%	-$66.1K	0.79%	38
2018 Q3	$1.67M	Sell	21,208 -1,827	-8%	-$131K	0.83%	32
2018 Q2	$1.48M	Buy	23,035 +4,823	+26%	+$318K	0.79%	34
2018 Q1	$1.13M	Buy	18,212 +1,635	+10%	+$117K	0.64%	45
2017 Q4	$1.2M	Sell	16,577 -4,435	-21%	-$322K	0.7%	41
2017 Q3	$1.71M	Sell	21,012 -1,065	-5%	-$84.2K	1.05%	25
2017 Q2	$1.78M	Sell	22,077 -1,650	-7%	-$130K	1.14%	23
2017 Q1	$1.86M	Sell	23,727 -660	-3%	-$52.7K	1.14%	23
2016 Q4	$1.92M	Buy	24,387 +2,970	+14%	+$240K	1.27%	21
2016 Q3	$1.91M	Sell	21,417 -848	-4%	-$80K	1.54%	18
2016 Q2	$2.13M	Sell	22,265 -835	-4%	-$83.2K	1.77%	12
2016 Q1	$2.4M	Sell	23,100 -3,625	-14%	-$352K	2.04%	8
2015 Q4	$2.61M	Buy	26,725 +73	+0.3%	+$7.15K	2.01%	8
2015 Q3	$2.57M	Buy	26,652 +1,031	+4%	+$108K	2%	9
2015 Q2	$2.69M	Buy	25,621 +290	+1%	+$29.6K	1.93%	7
2015 Q1	$2.61M	Buy	25,331 +1,163	+5%	+$118K	1.89%	8
2014 Q4	$2.33M	Buy	24,168 +2,050	+9%	+$181K	1.76%	11
2014 Q3	$1.76M	Buy	22,118 +910	+4%	+$71.7K	1.4%	16
2014 Q2	$1.6M	Buy	21,208 +590	+3%	+$44.6K	1.28%	21
2014 Q1	$1.54M	Buy	20,618 +1,046	+5%	+$73.9K	1.36%	21
2013 Q4	$1.4M	Buy	+19,572	New	+$1.26M	1.25%	20

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Blue Fin Capital's CVS Position: Q3 2024 in Review

Blue Fin Capital sold out of CVS Health (CVS) in Q3 2024, closing a stake of 8,684 shares — an estimated $513K sold.

Blue Fin Capital first reported a position in CVS in Q4 2013 and held it in 43 quarters. The position peaked at $3M in Q4 2021. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Blue Fin Capital reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Blue Fin Capital sold 8,684 CVS Health shares in Q3 2024, an estimated $513K.
Blue Fin Capital first reported a position in CVS Health in Q4 2013 and held it in 43 quarters.
Blue Fin Capital's CVS Health position peaked at $3M in Q4 2021.
1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Blue Fin Capital's 13F filing for Q3 2024, filed 5 Nov 2024.